A lawsuit was filed on behalf of investors in OHR Pharmaceutical Inc (NASDAQ: OHRP) shares over alleged securities laws violations.
San Diego, CA -- (SBWIRE) -- 02/28/2018 -- An investor in shares of OHR Pharmaceutical Inc (NASDAQ: OHRP), filed a Securities Laws lawsuit over alleged violations by OHR Pharmaceutical Inc.
Investors who purchased shares of OHR Pharmaceutical Inc (NASDAQ: OHRP) have certain options and for certain investors are short and strict deadlines running. Deadline: April 16, 2018. NASDAQ:OHRP investors should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
According to the complaint the plaintiff alleges on behalf of purchasers of OHR Pharmaceutical Inc (NASDAQ:OHRP) common shares between June 24, 2014 and January 4, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 24, 2014 and January 4, 2018, the defendants made false and/or misleading statements and/or failed to disclose that OHR Pharmaceutical Inc's lead product Squalamine would not produce vision improvements and was commercially not viable, and that as a result of the foregoing, Defendants' statements about OHR Pharmaceutical Inc's business, operations, and prospects were misleading and/or lacked a reasonable basis.
Those who purchased shares of OHR Pharmaceutical Inc (NASDAQ: OHRP) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels